![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1423-0232|85|1|44-52
ISSN: 0030-2414
Source: Oncology, Vol.85, Iss.1, 2013-07, pp. : 44-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Sequential erlotinib with gemcitabine in NSCLC
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 1, 2015-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase II Trial of Docetaxel Therapy in Patients with Advanced Hepatocellular Carcinoma
Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. :